Homepage | Heart
4 天之前 · Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments are highlighted in editorials and put in context with concise review articles. There is one free Editor’s Choice article in each issue, with open access options available to authors for all articles. Education in Heart ...
Bradyarrhythmias in patients with atrial fibrillation | Heart
The increasing burden of atrial fibrillation (AF) and significant morbidity/mortality associated with this arrhythmia encourage screening it in clinical practice, as recommended in current guidelines. It means opportunistic screening (in patients over 65 years) or systematic screening (in people above 75 years) by using clinical examination, followed by an ECG, 24-hour ECG monitoring or ...
Treating patients with ventricular ectopic beats | Heart
Ventricular ectopic beats (VEBs) are commonly seen in daily clinical practice. They are largely asymptomatic but can cause upsetting symptoms in some patients. In normal hearts, their occurrence is usually associated with no clinical significance. However, there are occasions where the presence of VEBs signifies a susceptibility towards more sinister arrhythmias, especially when heart disease ...
Heart failure with preserved ejection fraction: recent concepts in ...
It is estimated that half of all patients with heart failure (HF) have HF with preserved ejection fraction (HFpEF). Yet this form of HF remains a diagnostic and therapeutic challenge. Differentiating HFpEF from other causes of dyspnoea may require advanced diagnostic methods, such as exercise echocardiography, invasive haemodynamics and investigations for ‘HFpEF mimickers’. While the ...
Management of premature ventricular complexes | Heart
Learning objectives Care pathways for management of premature ventricular complexes (PVCs) including screening for structural heart disease, PVC burden, cause and effect relation with left ventricular dysfunction when present. Site of origin for common PVCs. Role of pharmacological therapy and catheter ablation. Risk stratification for sudden cardiac death.
Introduction: Coronary angiography (CAG) in the 2020s - Heart
The role of ‘stand-alone’ coronary angiography (CAG) in the management of patients with chronic coronary syndromes is the subject of debate, with arguments for its replacement with CT angiography on the one hand and its confinement to the interventional cardiac catheter laboratory on the other. Nevertheless, it remains the standard of care in most centres. Recently, computational methods ...
Calcium and vitamin D supplement: right or wrong? - Heart
Intuitively, one might think that supplementing vitamins and minerals would be the right thing to do especially in older and comorbid people. Every year, billions of dollars are spent in this belief.1 However, we may all be wrong. A present study in this journal demonstrates a significantly increased cardiovascular (CV) mortality in elderly patients supplementing calcium, be it …
2021年6月23日 · INTRODUCTION Peripheral artery disease (PAD) typically refers to atherosclerotic narrowing and/or occlusion of all arterial disease other than coronary arteries and the aorta (carotid and vertebral arteries, coeliac and mesenteric arteries, renal arteries and upper and lower limb arteries) (figure 1). As a manifestation of systemic atherosclerosis, PAD is associated with greatly increased ...
Does aspirin save lives in patients with COVID-19? | Heart
‘An aspirin a day keeps the heart attack away’, is this also true in the prevention of thrombotic events associated with COVID-19? The rising COVID-19 pandemic has led to much work in the understanding of the pathophysiology of the disease. COVID-19 infection is thought to be an endothelial disease. Supporting this concept, it has been …
2021年2月25日 · ABSTRACT Patients with type 2 diabetes mellitus are at a higher risk of developing heart failure compared with the healthy population. In recent landmark clinical trials, sodium- glucose co- transporter 2 (SGLT2) inhibitor therapies improve blood glucose control and also reduce cardiovascular events and heart failure hospitalisations in patients with type 2 diabetes. Intriguingly, such ...